Online citations, reference lists, and bibliographies.
← Back to Search

Contemporary Approach To The Diagnosis Of Malignant Pleural Effusion.

V. Kaul, D. McCracken, N. Rahman, O. Epelbaum
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Advanced malignancy is a prevalent cause of exudative pleural effusion. The management of malignant pleural effusion (MPE) has been the subject of several recent randomized controlled trials and excellent reviews. Less attention has been focused on another controversial and challenging aspect of MPE: it's diagnosis. Prior to selecting the optimal management strategy, the presence of an MPE must first be correctly identified with an emphasis on minimizing invasiveness and discomfort in a patient afflicted with late-stage cancer. The aim of the present review is to summarize the current knowledge about MPE diagnostics and to propose an algorithm for the diagnosis of MPE in established or suspected malignancy.
This paper references
10.1016/j.athoracsur.2018.02.044
Efficacy and Cost of Awake Thoracoscopy and Video-Assisted Thoracoscopic Surgery in the Undiagnosed Pleural Effusion.
Christine M. McDonald (2018)
10.1111/resp.12496
Clinical features and survival of lung cancer patients with pleural effusions
J. M. Porcel (2015)
10.2214/AJR.166.4.8610582
Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease.
F. Falaschi (1996)
10.1177/1753466618808660
Biomarkers in the diagnosis of pleural diseases: a 2018 update
J. M. Porcel (2018)
10.1158/1078-0432.CCR-13-2933
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver (2014)
10.1378/chest.09-0641
Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
J. Swiderek (2010)
10.1378/CHEST.107.3.845
The impact of thoracoscopy on the management of pleural disease.
R. J. Harris (1995)
10.1378/chest.14-0299
Physician-based ultrasound-guided biopsy for diagnosing pleural disease.
R. Hallifax (2014)
10.1378/CHEST.107.6.1598
Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
M. Marel (1995)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.1136/thoraxjnl-2014-206567
The utility of ultrasound-guided thoracentesis and pleural biopsy in undiagnosed pleural exudates
C. F. Koegelenberg (2015)
10.1016/S1470-2045(18)30294-8
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
I. Psallidas (2018)
10.1378/chest.09-0884
Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.
M. Metintas (2010)
10.1378/chest.14-0820
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. M. Porcel (2015)
10.1378/CHEST.126.6.1757
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
J. M. Porcel (2004)
10.1111/resp.13187
Non‐specific pleuritis in patients with active malignancy
Erik Vakil (2018)
10.1073/pnas.1612229114
High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients
Yin Tang (2017)
10.1136/thx.2008.100545
Thoracic ultrasound in the diagnosis of malignant pleural effusion
N. R. Qureshi (2008)
10.1183/13993003.01254-2018
Investigating unilateral pleural effusions: the role of cytology
D. Arnold (2018)
10.1126/scitranslmed.aaf6219
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
J. Tie (2016)
10.1111/crj.12125
Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients
L. Valdés (2015)
10.1136/jclinpath-2013-201728
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu (2013)
10.1111/crj.12256
Feasibility and safety of parietal pleural cryobiopsy during semi‐rigid thoracoscopy
A. Rozman (2016)
10.1016/J.CHEST.2017.08.548
Prevalence and Etiology of Pleural Effusions in Hospitalized Patients: An Analysis of HCUP-NIS 2012
N. Taghizadeh (2017)
10.1016/S1470-2045(16)00173-X
Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.
Morten Bendixen (2016)
10.1371/journal.pone.0161764
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion
Yajuan Sun (2016)
10.1038/s41598-017-19069-0
The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis
H. Zhou (2017)
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
M. Tamiya (2016)
10.1136/thoraxjnl-2014-206054
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
10.1016/j.ejcts.2010.01.057
Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
H. E. Davies (2010)
10.4103/0970-2113.188969
Thoracoscopic evaluation of 129 cases having undiagnosed exudative pleural effusions
C. B. Patil (2016)
10.1378/chest.08-2002
A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
W. Abouzgheib (2009)
10.1016/S0140-6736(03)13079-6
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
N. Maskell (2003)
10.1002/cncy.21342
The diagnosis of malignant mesothelioma in effusion cytology
A. Paintal (2013)
10.7326/0003-4819-108-3-345
Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.
S. Sahn (1988)
10.1016/S0140-6736(64)91536-3
THE CASE FOR EXFOLIATIVE CYTOLOGY OF SEROUS EFFUSIONS.
B. Naylor (1964)
10.1136/thx.2010.137018
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
N. Rahman (2010)
10.1159/000443483
CT Scan-Guided Abrams' Needle Pleural Biopsy versus Ultrasound-Assisted Cutting Needle Pleural Biopsy for Diagnosis in Patients with Pleural Effusion: A Randomized, Controlled Trial
M. Metintas (2016)
10.1002/cncy.21452
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases
Lisa M. Rooper (2014)
Thoracoscopy in undiagnosed pleural effusions.
M. D. de Groot (1998)
10.1158/1078-0432.CCR-15-1260
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
C. Karlovich (2016)
10.1510/icvts.2010.250357
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
A. Fiorelli (2011)
10.1148/radiol.12110872
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
J. Coolen (2012)
10.1378/CHEST.127.3.1017
Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.
J. Ferrer (2005)
10.1053/j.ro.2013.03.017
Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.
M. Truong (2013)
10.1016/0002-9343(77)90154-1
Carcinomatous involvement of the pleura: an analysis of 96 patients.
B. Chernow (1977)
10.1159/000247335
Narrow Band Imaging Applied to Pleuroscopy for the Assessment of Vascular Patterns of the Pleura
A. Ishida (2009)
10.1378/chest.13-2113
Feasibility and safety of outpatient medical thoracoscopy at a large tertiary medical center: a collaborative medical-surgical initiative.
Z. Depew (2014)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
C. Boutin (1993)
Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination.
K. Nance (1991)
10.1111/j.1365-2559.2008.03099.x
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma
R. Attanoos (2008)
10.4187/respcare.02738
A Randomized Trial Comparing the Diagnostic Yield of Rigid and Semirigid Thoracoscopy in Undiagnosed Pleural Effusions
S. Dhooria (2014)
10.1016/j.lungcan.2009.05.005
Closed pleural biopsy to diagnose mesothelioma: dead or alive?
K. McLaughlin (2009)
10.1378/CHEST.124.3.978
Etiology and pleural fluid characteristics of large and massive effusions.
J. M. Porcel (2003)
10.1016/J.ARBRES.2016.12.013
Utilidad de la medición de CEA y CA 15-3 en los exudados pleurales no purulentos para diagnosticar malignidad: experiencia de un único centro
J. M. Porcel (2017)
10.1136/thoraxjnl-2014-205285
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
A. Clive (2014)
10.1038/nrclinonc.2017.14
Integrating liquid biopsies into the management of cancer
G. Siravegna (2017)
Utility of contrast-enhanced ultrasound with SonoVue in biopsy of small subpleural nodules.
Jinlin Wang (2015)
10.1164/rccm.200801-062OC
Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose.
N. Rahman (2008)
10.21037/jtd.2017.06.37
Medical thoracoscopy and its evolving role in the diagnosis and treatment of pleural disease.
Vivek Murthy (2017)
10.1007/s00408-015-9831-6
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)
A. Verma (2015)
10.1016/J.ARBRES.2013.11.007
Etiología del derrame pleural: análisis de más de 3.000 toracocentesis consecutivas
J. M. Porcel (2014)
10.1038/nature22364
Phylogenetic ctDNA analysis depicts early stage lung cancer evolution
C. Abbosh (2017)
10.1378/chest.14-0013
Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.
J. M. Porcel (2015)
10.1164/rccm.200811-1729OC
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
H. E. Davies (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar